Talk:Ebola vaccine/Archive 1

US National stockpile[edit]

Hi, GGT - I'm not sure if the National Stockpile really fits in this article. The sentence about GlaxoSmithKline, NewLink etc reproduces material further up in this article; ZMAPP is a drug, not a vaccine, so it doesn't belong here. Cheers, Bob. Robertpedley (talk) 22:26, 30 March 2015 (UTC)[reply]

Hey there, that section seems to have been here for some time, since when the article was split in 2014 from Ebola virus disease. Someone probably made that list of companies before hardly anything was in detail. The second sentence of the section seems like a general statement as well, so I would say that we could preserve the first sentence (with a specific time reference to when the estimate was made) and get rid of the rest. --GGT (talk) 22:36, 30 March 2015 (UTC)[reply]

TKM update[edit]

TKM-Ebola-Guinea update rather vague wording, or am I missing something? LeadSongDog come howl! 13:03, 20 June 2015 (UTC)[reply]

tag/remove[edit]

have gone over the article, and while some non-reviews exist (references)its only because it is an ongoing process until a review or meta-analysis is available..IMO--Ozzie10aaaa (talk) 18:15, 19 July 2016 (UTC)[reply]

vaccine development[edit]

will go over this section to determine which are still relevant--Ozzie10aaaa (talk) 19:25, 20 July 2016 (UTC)[reply]

LeadSongDog come howl! several of the references on the table were not Wikipedia:Identifying_reliable_sources and have been removed because the text cannot be verified (nor could any reliable sources be found)....other references were updated--Ozzie10aaaa (talk) 23:40, 20 July 2016 (UTC)[reply]

"NewLink Genetics Awarded $25 Million Contract from BARDA for Investigational Ebola Zaire Vaccine (V920) (NASDAQ:NLNK)". investors.linkp.com. Retrieved 12 October 2016.--Ozzie10aaaa (talk) 16:43, 12 October 2016 (UTC)[reply]

(note the recently added archive box was done so per Help talk:Archiving a talk page#Need new example page on this talk page (and/or others) for possible future use, though the other archive is inactive, should any one disagree with the link please remove)..additional example was done at Talk:West African Ebola virus epidemic starting 2014 (not by me though),thank you--Ozzie10aaaa (talk) 18:20, 12 October 2016 (UTC)[reply]

Use[edit]

Has VSV EBOV been approved for medical use and is it commercially avaliable? From my understanding, not yet outside of a research setting which makes it still "in development" rather than in "clinical use" Doc James (talk · contribs · email) 04:47, 28 December 2016 (UTC)[reply]

yet worthy of mention...( the process to commercialization[1])--Ozzie10aaaa (talk) 11:07, 28 December 2016 (UTC)[reply]

Updates needed[edit]

Recent reviews:

"A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?". Philos Trans R Soc Lond B Biol Sci. 372 (1721). 26 May 2017. doi:10.1098/rstb.2016.0295. PMID 28396468. {{cite journal}}: Cite uses deprecated parameter |authors= (help)
"The ongoing evolution of antibody-based treatments for Ebola virus infection". Immunotherapy. 9 (5): 435–450. March 2017. doi:10.2217/imt-2017-0010. PMID 28357917. {{cite journal}}: Cite uses deprecated parameter |authors= (help)
"Closer than ever to an Ebola virus vaccine". Expert Rev Vaccines. 16 (5): 401–402. May 2017. doi:10.1080/14760584.2017.1309977. PMID 28322076. {{cite journal}}: Cite uses deprecated parameter |authors= (help)

LeadSongDog come howl! 19:24, 18 May 2017 (UTC)[reply]

Trials[edit]

It's unclear to me which vaccines this story is talking about, but it's an interesting update: China may compete with the West for limited opportunities to test Ebola vaccine -- Beland (talk) 18:16, 11 June 2018 (UTC)[reply]

will check--Ozzie10aaaa (talk) 18:20, 11 June 2018 (UTC)[reply]

Contradiction[edit]

The article says in the intro only VSV-EBOV is proven, and mentions only ZMapp as being in use in the 2018 outbreak, but a table shows VSV-EBOV as in use. Are these in use in different ways, or are they somehow related products? If they are different, they should both be mentioned in the intro and both be mentioned as in use, to avoid favoritism. -- Beland (talk) 18:46, 11 June 2018 (UTC)[reply]

I didn't find the contradiction. I didn't find where the intro says that only VSV-EBOV is proven; it says VSV-EBOV is the "first proven vaccine" (apparently ZMapp is the second). I didn't find where it says only ZMapp is in use in 2018; it says "the benefits of ZMapp outweigh its risks" but "it presented logistical challenges" and "Supplies of ZMapp ran out in October 2014." If there is a contradiction, I usually use {{contradict-inline}}. Art LaPella (talk) 20:15, 11 June 2018 (UTC)[reply]

concur w/ Art--Ozzie10aaaa (talk) 21:27, 11 June 2018 (UTC)[reply]

make paragraph: Side effects[edit]

Add specific data.— Preceding unsigned comment added by 2A02:587:411E:6F00:B9A0:4935:17BF:3428 (talk • contribs)

will look --Ozzie10aaaa (talk) 10:33, 3 August 2019 (UTC)[reply]

[edit]

Does anyone have updates on this crucial development? An effective Ebola vaccine would save many lives, correct? — Preceding unsigned comment added by 31.21.138.191 (talk) 08:36, 18 March 2020 (UTC)[reply]

yes it would--Ozzie10aaaa (talk) 11:52, 18 March 2020 (UTC)[reply]